|
- Retinopathy of Prematurity - National Eye Institute
Retinopathy of prematurity (ROP) is an eye disease that can happen in babies who are premature (born early) — or who weigh less than 3 pounds at birth ROP happens when abnormal blood vessels grow in the retina (the light-sensitive layer of tissue in the back of your eye) Some babies with ROP have mild cases and get better without treatment But some babies need treatment to protect their
- Retinopatía de la prematuridad - National Eye Institute
La retinopatía de prematuridad (ROP, por sus siglas en inglés), también conocida como retinopatía del prematuro, es una enfermedad ocular que puede afectar a los bebés prematuros (que nacen antes de tiempo) o que pesan menos de 3 libras al momento de nacer La retinopatía de prematuridad ocurre cuando crecen vasos sanguíneos anormales en la retina (la capa de tejido sensible a la luz
- Retinopathy of Prematurity Research - National Eye Institute
Retinopathy of prematurity (ROP) is an eye disease that causes abnormal blood vessels to grow in a baby’s retina (light-sensitive layer of tissue at the back of the eye) It happens in babies who are premature (born early) — or who weigh less than 3 pounds at birth Some babies with ROP develop retinal detachment, which can cause vision loss Clinical studies funded by NEI provide doctors
- Telemedicine catches blinding disease in premature babies
Telemedicine is an effective strategy to screen for the potentially blinding disease known as retinopathy of prematurity (ROP), according to a study funded by the National Eye Institute (NEI)
- NEI Research News - National Eye Institute
An inexpensive, smartphone-based camera can help doctors identify premature infants needing treatment for retinopathy of prematurity (ROP), according to a new study funded by the National Eye Institute (NEI)
- Very low-dose Avastin effective for preventing blindness in preterm . . .
Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently
- Study Confirms Value Of Treatment To Prevent Blindness In Premature . . .
In another NIH-supported study, researchers estimated that appropriate screening and treatment of ROP in premature infants would save society between $38 million and $65 million a year in special education, disability, and other costs, and in lost productivity
- Saving premature babies’ vision with a smartphone camera and artificial . . .
An inexpensive, smartphone-based camera can help doctors identify premature infants needing treatment for retinopathy of prematurity (ROP), according to a new study funded by the National Eye Institute (NEI)
|
|
|